Pharmacology

Medicare vs VA—VA Wins; Delaying Antibiotics for UTI; Dolutegravir Approved to Treat Resistant HIV Infection

If Medicare spent money on drugs the way the VA does, it could save millions of dollars without lowering the quality of what patients get, according to a study by researchers from the VA Center for Health Equity Research and Promotion, the University of Pittsburgh Graduate School of Public Health, and the University of Pittsburgh School of Pharmacy, all in Pittsburgh, Pennsylvania; and The Dartmouth Institute for Health Policy and Clinical Practice in Lebanon, New Hampshire.


 

Recommended Reading

Veterans May Have Been Exposed to HIV While Receiving VA Care
Federal Practitioner
A Case for Prioritizing Global Health Diplomacy
Federal Practitioner
Endoscopic Equipment Errors Leave Veterans at Risk
Federal Practitioner
VA Reports More Infections With Possible Links to Endoscopic Errors
Federal Practitioner
VA Report Says Endoscope Problems Continue
Federal Practitioner
VHA Facilities Improve Colonoscope Reprocessing Compliance
Federal Practitioner
Emerging Challenges in the Management of HIV and Hepatitis C Virus Coinfection in Veterans
Federal Practitioner
Resuming Continuous Antiretroviral Therapy After Episodic Treatment
Federal Practitioner
Effects of Psychosocial Issues on Medication Adherence Among HIV/AIDS Patients
Federal Practitioner
Venous Thromboembolism and Weight Changes in Veteran Patients Using Megestrol Acetate as an Appetite Stimulant
Federal Practitioner